Hackensack University Medical Center Multiple Myeloma Division — Hackensack, New Jersey

Hackensack University Medical Center Multiple Myeloma Division is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Hackensack University Medical Center Multiple Myeloma Division has participated in 2 clinical trials.

Therapeutic areas: Multiple Myeloma, Smoldering Multiple Myeloma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hackensack University Medical Center Multiple Myeloma Division?

Hackensack University Medical Center Multiple Myeloma Division has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hackensack University Medical Center Multiple Myeloma Division conducted?

Hackensack University Medical Center Multiple Myeloma Division has 2 clinical trials on record. Their work covers Multiple Myeloma, Smoldering Multiple Myeloma.

Is Hackensack University Medical Center Multiple Myeloma Division accredited by Crixeo Health?

Hackensack University Medical Center Multiple Myeloma Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hackensack University Medical Center Multiple Myeloma Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.